Siemens Healthcare GmbH-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Siemens Healthcare GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013284
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Siemens Healthcare GmbH d/b/a Siemens Healthineers, a subsidiary of Siemens AG, is a global medical device company that designs, develops, manufactures and distributes medical devices and technologies for diagnostic markets. Its major products include healthcare IT and medical infrastructure solutions, laboratory diagnostics equipment, medical imaging equipment, point-of-care testing devices, medical accessories, OEM component and medical electronics solutions and refurbished systems for medical imaging and therapy. Its products and solutions are utilized in the areas including cardiology, neurology, oncology, surgery, women’s health, diabetes, infectious disease, urology, organ transplant, therapeutic drug monitoring and growth disorders, among others. The company operates in Europe, the Americas, Africa and Asia-Pacific. Siemens Healthineers is headquartered in Erlangen, Germany.

Siemens Healthcare GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Siemens Healthcare GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Siemens Healthcare GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Siemens Healthcare GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Siemens Healthcare GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Siemens Healthcare GmbH, Medical Devices Deals, 2011 to YTD 2017 9
Siemens Healthcare GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Siemens Healthcare GmbH, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Siemens Healthcare Diagnostics Completes Acquisition Of Manufacturing Plant In Mishawaka From Bayer HealthCare 11
Venture Financing 12
NEO New Oncology Raises USD5.6 Million in Financing Round 12
Partnerships 13
Siemens Healthcare Enters into Co-Development Agreement with Biogen 13
New Oncology Enters into Research Agreement with Gustave Roussy Cancer Campus 14
Siemens Healthcare Diagnostics Enters Into Co-Development Agreement With JEOL USA 15
Rhoen-Klinikum Enters Into Co-Development Agreement With Siemens 16
Siemens Healthcare Diagnostics Enters Into Co-Marketing Agreement With Copan Diagnostics 17
Siemens Healthcare Diagnostics Enters Into Co-Marketing Agreement With Bruker 18
Equity Offering 19
Siemens Healthcare Plans IPO of Shares 19
Asset Transactions 20
InterSystems Acquires Siemens Health Services France From Siemens Healthcare 20
Siemens Healthcare GmbH – Key Competitors 21
Siemens Healthcare GmbH – Key Employees 22
Siemens Healthcare GmbH – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Joint Venture 26
Recent Developments 27
Strategy And Business Planning 27
Jun 30, 2017: Siemens Breaks Ground in Walpole, Mass., Marks Milestone in its Investment Strategy for Healthcare Market Transformation 27
Other Significant Developments 29
Jun 15, 2016: Siemens Healthcare Becomes Siemens Healthineers 29
May 04, 2016: Siemens Healthineers – The new brand for Siemens’ healthcare business 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Siemens Healthcare GmbH, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Siemens Healthcare GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Siemens Healthcare GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Siemens Healthcare GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Siemens Healthcare GmbH, Deals By Therapy Area, 2011 to YTD 2017 8
Siemens Healthcare GmbH, Medical Devices Deals, 2011 to YTD 2017 9
Siemens Healthcare GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Siemens Healthcare Diagnostics Completes Acquisition Of Manufacturing Plant In Mishawaka From Bayer HealthCare 11
NEO New Oncology Raises USD5.6 Million in Financing Round 12
Siemens Healthcare Enters into Co-Development Agreement with Biogen 13
New Oncology Enters into Research Agreement with Gustave Roussy Cancer Campus 14
Siemens Healthcare Diagnostics Enters Into Co-Development Agreement With JEOL USA 15
Rhoen-Klinikum Enters Into Co-Development Agreement With Siemens 16
Siemens Healthcare Diagnostics Enters Into Co-Marketing Agreement With Copan Diagnostics 17
Siemens Healthcare Diagnostics Enters Into Co-Marketing Agreement With Bruker 18
Siemens Healthcare Plans IPO of Shares 19
InterSystems Acquires Siemens Health Services France From Siemens Healthcare 20
Siemens Healthcare GmbH, Key Competitors 21
Siemens Healthcare GmbH, Key Employees 22
Siemens Healthcare GmbH, Other Locations 23
Siemens Healthcare GmbH, Subsidiaries 25
Siemens Healthcare GmbH, Joint Venture 26

★海外企業調査レポート[Siemens Healthcare GmbH-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ascent Resources Plc (AST):石油・ガス:M&Aディール及び事業提携情報
    Summary Ascent Resources Plc. (Ascent) is an independent upstream exploration and production company. It explores for, develops and produces oil and natural gas from its project in Slovenia. It operates the Petisovci tight gas project in Slovenia. The Petisovci Tight Gas project is in proximity to t …
  • Astrazeneca Pharma India Ltd (ASTRAZEN):企業の財務・戦略的SWOT分析
    Summary AstraZeneca Pharma India Ltd (AstraZeneca), is a biopharmaceutical company that discovers, develops, and commercializes medicines. The company offers products in the therapeutic areas including cardiovascular and metabolic diseases, respiratory, maternal healthcare, oncology, infection, neur …
  • SK Kaken Co Ltd (4628):企業の財務・戦略的SWOT分析
    SK Kaken Co Ltd (4628) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Alkermes Plc (ALKS)-製薬・医療分野:企業M&A・提携分析
    Summary Alkermes Plc (Alkermes) is a biopharmaceutical company that focuses on the research, development and commercialization of drugs for the treatment of central nervous system (CNS) diseases. The company’s proprietary products include Aristada, an extended-release intramuscular injectable suspen …
  • GIZEH Raucherbedarf GmbH:企業の戦略的SWOT分析
    GIZEH Raucherbedarf GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • PetSmart, Inc.:企業の戦略・SWOT・財務情報
    PetSmart, Inc. - Strategy, SWOT and Corporate Finance Report Summary PetSmart, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • DreamWorks Animation LLC:企業の戦略的SWOT分析
    DreamWorks Animation LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Integrated DNA Technologies Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Integrated DNA Technologies Inc (IDT) is a biotechnology company that develops diagnostic test products. The company’s products include DNA and RNA synthesis, genotyping, modifications, nextgen sequencing, gene silencing, synthesis genes, and purifications, among others. It offers services s …
  • NXP Semiconductors NV (NXPI):企業の財務・戦略的SWOT分析
    NXP Semiconductors NV (NXPI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Maruho Co Ltd:企業の戦略的SWOT分析
    Maruho Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Belize Electricity Ltd:企業の戦略的SWOT分析
    Belize Electricity Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • PetroNeft Resources plc (P8ET):石油・ガス:M&Aディール及び事業提携情報
    Summary PetroNeft Resources Plc (PetroNeft) is an upstream oil and gas company. It carries out exploration, development and production of oil and natural gas. The company mainly focuses on oil rich Western Siberia zone in Russia. PetroNeft’s asset base comprises of 50% interest each in License 61 an …
  • BioMarker Strategies LLC-医療機器分野:企業M&A・提携分析
    Summary BioMarker Strategies LLC (BioMarker Strategies) is a biotechnology company that develops tissue-based cancer diagnostic systems. The company offers cancer diagnostics system for predictive tests to targeted treatments for solid tumor malignancies. It also offers pathmap functional signaling …
  • Great Wolf Resorts Inc:企業の戦略・SWOT・財務情報
    Great Wolf Resorts Inc - Strategy, SWOT and Corporate Finance Report Summary Great Wolf Resorts Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Toshiba Corporation:企業の戦略・SWOT・財務分析
    Toshiba Corporation - Strategy, SWOT and Corporate Finance Report Summary Toshiba Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Bangkok Insurance Pcl:企業の戦略・SWOT・財務分析
    Bangkok Insurance Pcl - Strategy, SWOT and Corporate Finance Report Summary Bangkok Insurance Pcl - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Intelligent InSites Inc:医療機器:M&Aディール及び事業提携情報
    Summary Intelligent InSites Inc (Insites) is a provider of real-time operational intelligence for the health care industry. The company offers implementation, training, technical support, product maintenance and solution services. Its solutions include additional end-user training, additional integr …
  • Coppermoly Limited:企業の戦略・SWOT・財務情報
    Coppermoly Limited - Strategy, SWOT and Corporate Finance Report Summary Coppermoly Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • John Wood Group Plc (WG.):企業の財務・戦略的SWOT分析
    John Wood Group Plc (WG.) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • DexTech Medical AB:製薬・医療:M&Aディール及び事業提携情報
    Summary DexTech Medical AB (DexTech) is a research company that conducts research in the areas of urological oncology, mainly within prostate cancer. The company develops product candidates based on a modified carbon hydrate molecule combined with active substances such as generics. Its technology p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆